J2175
J2175 – Injection, meperidine hydrochloride, per 100 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 30 NDCs crosswalked per 100 MG $6.339/unit ASP+6%
📋 J2175 summary
J2175 is a HCPCS Level II J-code used to bill meperidine hydrochloride, per 100 mg, billed per 100 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2175: Demerol*, Demerol, Meperidine Hydrochloride
Code J2175
Billing unit 100 MG Payment limit $6.339/unit NDC-Crosswalk 30
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2175
DescriptorInjection, meperidine hydrochloride, per 100 mg
Billing unit100 MG
Payment limit / unit$6.339
Est. ASP / unit$5.980 est.
Mapped NDCs30
Data periodQ3 2026
Last updated2026-08-20
💊 About Meperidine Injection DRUG GUIDE
Meperidine injection is indicated for the management of pain severe enough to require an opioid and for which other treatments are inadequate.
It is reserved for patients who have not tolerated or have not gotten enough relief from non-opioid or combination pain medicines.Demerol Injection is also used as a preoperative medication (given before surgery), to support anesthesia during surgical procedures, and for obstetrical analgesia (pain relief during labor and delivery).
Clinical overview from our editorial drug guide for Meperidine Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$6.339
Est. ASP / unit
$5.980 est.
Est. after 2% sequester
$6.212
HCPCS dosage
100 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, meperidine hydrochloride, per 100 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date1997-01-01
Date added1986-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2175 = 100 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2175 WITH EST. MEDICARE PAY
30 NDCs map to J2175. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($6.339/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00409-1176-30 | DEMEROL MEPERIDINE HYDROCHLORIDE 25 mg/mL INJECTION, SOLUTION | Hospira, | 10 CARTRIDGE in 1 CARTON (0409-1176-30) /... | 25 mg/mL | 3 | $19.02 | — | ● Active | CMS + PDAC |
| 00409-1178-30 | DEMEROL MEPERIDINE HYDROCHLORIDE 50 mg/mL INJECTION, SOLUTION | Hospira, | 10 CARTRIDGE in 1 CARTON (0409-1178-30) /... | 50 mg/mL | 5 | $31.70 | — | ● Active | CMS + PDAC |
| 00409-1179-30 | DEMEROL MEPERIDINE HYDROCHLORIDE 75 mg/mL INJECTION, SOLUTION | Hospira, | 10 CARTRIDGE in 1 CARTON (0409-1179-30) /... | 75 mg/mL | 8 | $50.71 | — | Obsolete | CMS + PDAC |
| 00409-1180-69 | Demerol | Pfizer | — | — | 10 | $63.39 | — | — | CMS + PDAC |
| 00409-1181-30 | DEMEROL MEPERIDINE HYDROCHLORIDE 50 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-1181-... | 50 mg/mL | 15 | $95.09 | — | ● Active | CMS + PDAC |
| 00409-1362-01 | Demerol | Pfizer | — | — | 3 | $19.02 | — | — | CMS + PDAC |
| 00409-1418-01 | Demerol | Pfizer | — | — | 5 | $31.70 | — | — | CMS + PDAC |
| 00641-6052-25 | MEPERIDINE HYDROCHLORIDE 25 mg/mL INJECTION | Hikma | 25 VIAL in 1 CARTON (0641-6052-25) / 1 mL... | 25 mg/mL | 7 | $44.37 | — | ● Active | CMS ASP |
| 00641-6053-25 | MEPERIDINE HYDROCHLORIDE 50 mg/mL INJECTION | Hikma | 25 VIAL in 1 CARTON (0641-6053-25) / 1 mL... | 50 mg/mL | 13 | $82.41 | — | ● Active | CMS ASP |
| 00641-6054-25 | MEPERIDINE HYDROCHLORIDE 100 mg/mL INJECTION | Hikma | 25 VIAL in 1 CARTON (0641-6054-25) / 1 mL... | 100 mg/mL | 25 | $158.48 | — | ● Active | CMS ASP |
| 51927-1018-00 | MEPERIDINE HYDROCHLORIDE 1 kg/kg POWDER | Professional | 1 kg in 1 CONTAINER (51927-1018-0) | 1 kg/kg | 10 | $63.39 | — | ● Active | PDAC |
| 51552-0686-06 | MEPERIDINE HYDROCHLORIDE (USP,1X100GM) | Unknown | — | — | 10 | $63.39 | — | — | PDAC |
| 51552-0686-04 | MEPERIDINE HYDROCHLORIDE (USP,1X25GM) | Unknown | — | — | 10 | $63.39 | — | — | PDAC |
| 51552-0686-02 | MEPERIDINE HYDROCHLORIDE (USP,1X5GM) | Unknown | — | — | 10 | $63.39 | — | — | PDAC |
| 51552-0686-01 | MEPERIDINE HYDROCHLORIDE (USP,1X1GM) | Unknown | — | — | 10 | $63.39 | — | — | PDAC |
| 00406-1585-55 | meperidine hydrochloride 1 kg/kg POWDER | SpecGx | .025 kg in 1 BOTTLE (0406-1585-55) | 1 kg/kg | 10 | $63.39 | — | ● Active | PDAC |
| 38779-1766-05 | Meperidine HCl 1 g/g POWDER | Medisca | 100 g in 1 BOTTLE, GLASS (38779-1766-5) | 1 g/g | 10 | $63.39 | — | ● Active | PDAC |
| 38779-1766-04 | Meperidine HCl 1 g/g POWDER | Medisca | 25 g in 1 BOTTLE, GLASS (38779-1766-4) | 1 g/g | 10 | $63.39 | — | ● Active | PDAC |
| 38779-1766-03 | Meperidine HCl 1 g/g POWDER | Medisca | 5 g in 1 BOTTLE, GLASS (38779-1766-3) | 1 g/g | 10 | $63.39 | — | ● Active | PDAC |
| 00338-2691-75 | MEPERIDINE HCL (SRN,PREFILLED,GLASS) 10 MG/ML | Unknown | — | — | 0.1 | $0.63 | — | — | PDAC |
| 00409-1254-01 | DEMEROL (25X1.5ML) 50 MG/ML | Unknown | — | — | 0.5 | $3.17 | — | — | PDAC |
| 00409-1201-20 | DEMEROL (MDV) 100 MG/ML | Unknown | — | — | 1 | $6.34 | — | — | PDAC |
| 00409-1256-01 | DEMEROL HYDROCHLORIDE (25X1ML,LATEX-FREE) 100 MG/ML | Unknown | — | — | 1 | $6.34 | — | — | PDAC |
| 00409-1253-01 | DEMEROL HYDROCHLORIDE (LATEX-FREE) 50 MG/ML | Unknown | — | — | 0.5 | $3.17 | — | — | PDAC |
| 00409-1203-01 | DEMEROL HYDROCHLORIDE (UNI-AMP, 5X5,LATEX-FREE) 50 MG/ML | Unknown | — | — | 0.5 | $3.17 | — | — | PDAC |
| 00409-1255-02 | DEMEROL HYDROCHLORIDE (UNI-AMP 5X5,LATEX-FREE) 50 MG/ML | Unknown | — | — | 0.5 | $3.17 | — | — | PDAC |
| 61553-0170-41 | MEPERIDINE HCL/SODIUM CHLORIDE (INTRAVIA) 500 MG/50 ML-0.9% | Unknown | — | — | 0.1 | $0.63 | — | — | PDAC |
| 61553-0172-48 | MEPERIDINE HCL/SODIUM CHLORIDE (INTRAVIA) 1 GM/100 ML-0.9% | Unknown | — | — | 0.1 | $0.63 | — | — | PDAC |
| 63275-7100-04 | MEPERIDINE HCL (U.S.P.) | Unknown | — | — | 10 | $63.39 | — | — | PDAC |
| 63275-7100-05 | MEPERIDINE HCL (U.S.P.) | Unknown | — | — | 10 | $63.39 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$3.4K
Claims
408
Beneficiaries
352
Spend / beneficiary
$9.76
Spend / claim
$8.42
Trend by period
Where J2175 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #722 of 824
#717
COMIRNATY (5-11Y)* 91319
$3.8K
#718
ERAXIS J0348
$3.8K
#719
ACETAMINOPHEN(J0131) J0131
$3.7K
#720
VASOPRESSIN-0.9% NAC... J2601
$3.7K
#721
DDAVP* J2597
$3.6K
#722
DEMEROL* J2175
$3.4K
#723
LEVOTHYROXINE SODIUM... J0650
$3.4K
#724
MESNA* J9209
$3.4K
#725
CYSTO-CONRAY II* Q9958
$3.3K
#726
ENGERIX-B PEDIATRIC-... 90744
$3.2K
#727
TESTOSTERONE ENANTHA... J3121
$3.1K
Total claims — #471 of 824
#466
ELITEK J2783
468
#467
ARSENIC TRIOXIDE* J9017
453
#468
CYCLOPHOSPHAMIDE(J90... J9074
432
#469
MOZOBIL* J2562
424
#470
ADVATE* J7192
424
#471
DEMEROL* J2175
408
#472
VINBLASTINE SULFATE J9360
407
#473
DAXXIFY J0589
404
#474
ILARIS J0638
399
#475
ILUVIEN J7313
399
#476
COMPLETE SL PER SQ C... Q4270
396
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $3.4K | 352 | 408 | $9.76 | $8.42 |
| 2025 (Q1-Q4) | $23.7K | 1,492 | 2,180 | $15.86 | $10.86 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$18.7K
Medicare paid
$18.1K
Submitted services
2,202
Denial rate
15.8%
Allowed / service
$10.12
Submitted charges
$52.9K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J2175 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 2,260 services across 13 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J2175
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
30 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2175 billing FAQ
What is HCPCS code J2175?
J2175 is a HCPCS Level II J-code used to bill Injection, meperidine hydrochloride, per 100 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2175?
One unit of J2175 represents 100 MG. Report the number of units equal to the dose administered divided by 100 MG.
How many units of J2175 should I bill?
Divide the dose administered by the code's unit size (100 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2175?
The Medicare Part B payment limit is $6.339 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $6.212 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2175?
30 NDCs currently map to J2175 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2175 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.